Stock listing

Intellia Therapeutics, Inc.

Selected listing: 0JBU · LSE · USD · GB

Intellia Therapeutics, Inc. (LSE:0JBU), Health Technology. Latest release Oct 2, 2026: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing…

0JBU:LSEUSDGBUpdated October 9, 2026

Ticker: LSE:0JBU
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LSE
Currency: USD

About Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.

Latest news from Intellia Therapeutics, Inc.

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 2, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

September 8, 2026

Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million

September 4, 2026

Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference

September 4, 2026

Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates

July 30, 2026

All Intellia Therapeutics, Inc. news →

Events

Replays

Intellia Therapeutics, Inc. (NTLA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:00 AM ET
Watch
Intellia Therapeutics, Inc. (NTLA) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 06:00 PM ET
Watch

Research Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. company profile

View the public company page for Intellia Therapeutics, Inc. on 6ix.

Intellia Therapeutics, Inc. news

Read company news and market updates connected to Intellia Therapeutics, Inc..

Intellia Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Intellia Therapeutics, Inc..